Elio Adib (@adib_elio) 's Twitter Profile
Elio Adib

@adib_elio

Resident @HarvardRadOnc | @BrighamMedRes '23 @AUB_FM '19 | Cancer Epigenomics | views = own

ID: 1075650377243131904

linkhttps://scholar.google.com/citations?user=jCDc42EAAAAJ&hl=en calendar_today20-12-2018 07:13:29

564 Tweet

1,1K Followers

881 Following

Harvard Radiation Oncology Program (@harvardradonc) 's Twitter Profile Photo

We are so excited to announce our incoming radiation oncology residents! Please give a warm welcome to the Class of 2030! #Match2025 #matchday #radonc

We are so excited to announce our incoming radiation oncology residents! Please give a warm welcome to the Class of 2030! #Match2025 #matchday #radonc
Elio Adib (@adib_elio) 's Twitter Profile Photo

Feeling immense pride seeing my fellow Lebanese colleagues from American University of Beirut/Faculty of Medicine and across Lebanon matching into top residency programs nationwide! Lebanese talent continues to shine bright despite all challenges 🇱🇧 #MatchDay2025

NYU Langone Health (@nyulangone) 's Twitter Profile Photo

We are thrilled to announce the appointment of Alec C. Kimmelman, MD, PhD, as the next Chief Executive Officer at NYU Langone Health and Dean of NYU Grossman School of Medicine effective September 1, 2025. Learn more: nyulangone.org/news/nyu-lango…

We are thrilled to announce the appointment of Alec C. Kimmelman, MD, PhD, as the next Chief Executive Officer at <a href="/nyulangone/">NYU Langone Health</a> and Dean of <a href="/nyugrossman/">NYU Grossman School of Medicine</a> effective September 1, 2025.

Learn more: nyulangone.org/news/nyu-lango…
Elio Adib (@adib_elio) 's Twitter Profile Photo

NARLAL2 showed no evidence of ⬆️ GI or lung toxicity from PET-guided ☢️ dose escalation ~88 Gy (vs. 66 Gy) in LA-NSCLC! Potential LR control benefit in prior #ESTRO presentation 👏 ascopubs.org/doi/10.1200/JC… #lcsm

NARLAL2 showed no evidence of ⬆️ GI or lung toxicity from PET-guided ☢️ dose escalation ~88 Gy (vs. 66 Gy) in LA-NSCLC! 
Potential LR control benefit in prior #ESTRO presentation 👏 
ascopubs.org/doi/10.1200/JC…

#lcsm
Elio Adib (@adib_elio) 's Twitter Profile Photo

🌟Brilliant friend and future surgeon Elias Bou Farhat presenting his Conquer Cancer, the ASCO Foundation award-winning abstract on multimodal biomarkers of T-Dxd efficacy in advanced breast cancer #bcsm #ASCO25

🌟Brilliant friend and future surgeon <a href="/boufarhat_elias/">Elias Bou Farhat</a> presenting his <a href="/ConquerCancerFd/">Conquer Cancer, the ASCO Foundation</a> award-winning abstract on multimodal biomarkers of T-Dxd efficacy in advanced breast cancer #bcsm #ASCO25
Harvard Radiation Oncology Program (@harvardradonc) 's Twitter Profile Photo

It's that time of year again! HROP will be hosting a virtual open house for medical students interested in learning more about our residency program. Sign up here: forms.gle/9Awi2McwuNbfAr… #match2026 #ERAS #radonc #MedTwitter

It's that time of year again! HROP will be hosting a virtual open house for medical students interested in learning more about our residency program. Sign up here: forms.gle/9Awi2McwuNbfAr… #match2026 #ERAS #radonc #MedTwitter
Dr. Antonio Calles 🫁🚭 (@tony_calles) 's Twitter Profile Photo

☢️ Finally published the High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy for LS-SCLC. ✅OS 43.5 versus 22.5 mo, (HR 0.68, 95% CI 0.48–0.98, p = 0.037) No more acute or late onset toxicity. ✅ Would you now consider 60 Gy bid the new standard of care? #LCSM

Christian Adib (@adibchristian) 's Twitter Profile Photo

للأصدقاء في لبنان: قداس وجناز على راحة نفس والدي المرحوم طانيوس أديب يوم الأحد ٢٤ آب في تمام الساعة العاشرة صباحاً في كنيسة مار جرجس — صربا. اذكروه في صلواتكم كان رجلاً لا مثيل له.

للأصدقاء في لبنان: قداس وجناز على راحة نفس والدي المرحوم طانيوس أديب يوم الأحد ٢٤ آب في تمام الساعة العاشرة صباحاً في كنيسة مار جرجس — صربا. اذكروه في صلواتكم كان رجلاً لا مثيل له.
Elio Adib (@adib_elio) 's Twitter Profile Photo

Very interesting data on use of GLP1 agonists and ⬇️ cancer risk in adults. Early splitting of curves after a few months of follow-up ➡️ a cause for doubt 🤔?

The Nobel Prize (@nobelprize) 's Twitter Profile Photo

Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their groundbreaking discoveries concerning peripheral immune tolerance that prevents the immune system from harming the body. The Nobel Prize laureates

Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their groundbreaking discoveries concerning peripheral immune tolerance that prevents the immune system from harming the body.

The Nobel Prize laureates
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

📣 #ESMO25: NORTHSTAR RCT @YasirElaminMD; n=120 EGFR-mut #lungcancer osimertinib +/- LCT (68% #radiotherapy) ⬆️ 12-month PFS rate: 72% vs 54% ⬆️ PFS (25.3 vs 17.5 mo; HR 0.66; P=0.025) 😳 really not “oligo” population! ✅Grade ≥3 AEs: 29% (LCT arm) vs 22% (control) #radonc

📣 #ESMO25: NORTHSTAR RCT @YasirElaminMD; n=120 EGFR-mut  #lungcancer osimertinib +/- LCT (68%  #radiotherapy)
⬆️ 12-month PFS rate: 72% vs 54%
⬆️ PFS (25.3 vs 17.5 mo; HR 0.66; P=0.025) 
😳 really not “oligo” population!
✅Grade ≥3 AEs: 29% (LCT arm) vs 22% (control) #radonc